Patrick J. Heron
Director at Arcutis Biotherapeutics · 10 reported transactions in 4 companies · latest trade Jan 23, 2026
Their record
Across their whole record, 3 purchases can be measured; 3 did better than the S&P 500 over the next 6 months.
Typical move +63.8%, S&P 500 +7.8% over the same days.
Their trades
Bought | Jan 23, 2026 | Jan 23, 2026 close $94.29 → Oct 29, 2026 close $86.39. S&P 500 +12.1% over the same days. | ||
Bought | Sep 26, 2025 | Sep 26, 2025 close $17.51 → Oct 29, 2026 close $54.54. S&P 500 +16.7% over the same days. | ||
Bought | Jun 13, 2025 | Jun 13, 2025 close $13.43 → Oct 29, 2026 close $31.97. S&P 500 +29.4% over the same days. | ||
Bought | Jun 5, 2025 | Jun 5, 2025 close $13.51 → Oct 29, 2026 close $31.97. S&P 500 +30.2% over the same days. | ||
Bought | Jun 4, 2025 | Jun 4, 2025 close $13.27 → Oct 29, 2026 close $31.97. S&P 500 +29.6% over the same days. |
BoughtMirum Pharmaceuticals
$9M
Jan 23, 2026 close $94.29 → Oct 29, 2026 close $86.39. S&P 500 +12.1% over the same days.
BoughtMBX Biosciences
$12M
Sep 26, 2025 close $17.51 → Oct 29, 2026 close $54.54. S&P 500 +16.7% over the same days.
BoughtArcutis Biotherapeutics
$34.6K
Jun 13, 2025 close $13.43 → Oct 29, 2026 close $31.97. S&P 500 +29.4% over the same days.
BoughtArcutis Biotherapeutics
$5.1K
Jun 5, 2025 close $13.51 → Oct 29, 2026 close $31.97. S&P 500 +30.2% over the same days.
BoughtArcutis Biotherapeutics
$25.2K
Jun 4, 2025 close $13.27 → Oct 29, 2026 close $31.97. S&P 500 +29.6% over the same days.